Nerea Marcotegui

669 total citations
12 papers, 374 citations indexed

About

Nerea Marcotegui is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nerea Marcotegui has authored 12 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Hematology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nerea Marcotegui's work include Acute Myeloid Leukemia Research (8 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Nerea Marcotegui is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Nerea Marcotegui collaborates with scholars based in Spain, United States and Guatemala. Nerea Marcotegui's co-authors include María D. Odero, Carmen Vicente, Marı́a José Calasanz, Ion Cristóbal, Laura García-Ortí, J. Rifón, Eva Bandrés, Francisco J. Blanco, Francisco J. Novo and Carmelo Bernabéu and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Nerea Marcotegui

12 papers receiving 370 citations

Peers

Nerea Marcotegui

HEMAT

GENET

ONCOL

Aditya Shroff United States

Laura García-Ortí Spain

Marianne Santaguida United States

Rodolphe F. Taby United States

Sara E. Meyer United States

Olaf Hopfer Germany

Petra Zeisberger Germany

Lisa von Paleske Germany

Inmaculada Rapado Spain

Kristina Brumme United States

Aditya Shroff United States

Nerea Marcotegui

319 ×1.1

161 ×1.0

HEMAT

102 ×1.4

40 ×0.8

GENET

53 ×1.2

ONCOL

Citations per year, relative to Nerea Marcotegui Nerea Marcotegui (= 1×) peers Aditya Shroff

Countries citing papers authored by Nerea Marcotegui

Since Specialization

Citations

This map shows the geographic impact of Nerea Marcotegui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nerea Marcotegui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nerea Marcotegui more than expected).

Fields of papers citing papers by Nerea Marcotegui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nerea Marcotegui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nerea Marcotegui. The network helps show where Nerea Marcotegui may publish in the future.

Co-authorship network of co-authors of Nerea Marcotegui

This figure shows the co-authorship network connecting the top 25 collaborators of Nerea Marcotegui. A scholar is included among the top collaborators of Nerea Marcotegui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nerea Marcotegui. Nerea Marcotegui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Marcotegui, Nerea, et al.. (2023). Set Protein Is Involved in FLT3 Membrane Trafficking. Cancers. 15(8). 2233–2233. 5 indexed citations

Farrington, Caroline, Elena Arriazu, Nerea Marcotegui, et al.. (2022). Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 141(9). 1047–1059. 15 indexed citations

Arriazu, Elena, Carmen Vicente, Raffaella Pippa, et al.. (2020). A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia. Blood Cancer Journal. 10(1). 3–3. 28 indexed citations

Vicente, Carmen, Elena Arriazu, Nerea Marcotegui, et al.. (2019). A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. Cancer Letters. 468. 1–13. 33 indexed citations

Maicas, Miren, Iria Vázquez, Rafael Alis, et al.. (2017). The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1860(6). 721–729. 15 indexed citations

Pippa, Raffaella, Ana Lucía Dominguez, Raquel Malumbres, et al.. (2016). MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia. Oncotarget. 8(33). 53989–54003. 26 indexed citations

García-Ortí, Laura, Ion Cristóbal, Cristina Cirauqui, et al.. (2012). Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia. PLoS ONE. 7(10). e47717–e47717. 36 indexed citations

Maicas, Miren, Iria Vázquez, Carmen Vicente, et al.. (2012). Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription. Oncogene. 32(16). 2069–2078. 22 indexed citations

Vázquez, Iria, Miren Maicas, Javier Lizardi Cervera, et al.. (2011). Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Haematologica. 96(10). 1448–1456. 42 indexed citations

10.

Gómez‐Benito, María José, Ana Conchillo, Miguel A. Garcı́a, et al.. (2010). EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2. British Journal of Cancer. 103(8). 1292–1296. 31 indexed citations

11.

Cristóbal, Ion, Francisco J. Blanco, Laura García-Ortí, et al.. (2009). SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Blood. 115(3). 615–625. 120 indexed citations

12.

Lahortiga, Idoya, Iria Vázquez, Nerea Marcotegui, et al.. (2005). GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.. Blood. 106(11). 2378–2378. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact